OpenURL Connection Search

Select item for more details and to access through your institution.

Outcomes of relapse in patients with deferred autologous stem cell transplant after achieving at least very good partial response following bortezomib, adriamycin, dexamethasone chemotherapy for newly diagnosed multiple myeloma in the phase II PADIMAC trial
Published in:
British Journal of Haematology, 2022, v. 196, n. 4, p. e33, doi. 10.1111/bjh.17903
By:
- Chan, Wei Yee;
- Counsell, Nicholas;
- de Tute, Ruth;
- De‐Silva, Dunnya;
- Phillips, Elizabeth H.;
- Cavenagh, Jamie;
- Adedayo, Toyin;
- Braganca, Nivette;
- Roddie, Claire;
- Streetly, Matthew;
- Schey, Stephen;
- Koh, Mickey B.C.;
- Crowe, Josephine;
- Morris, Treen C.;
- Cook, Gordon;
- Clifton‐Hadley, Laura;
- Rabin, Neil;
- Owen, Roger G.;
- Popat, Rakesh;
- Yong, Kwee L.
Publication type:
Article
Using depth of response to stratify patients to front line Autologous Stem Cell Transplant: results of the phase II PADIMAC Myeloma Trial.
Published in:
British Journal of Haematology, 2021, v. 193, n. 3, p. e19, doi. 10.1111/bjh.17391
By:
- Popat, Rakesh;
- Counsell, Nicholas;
- de Tute, Ruth;
- De‐Silva, Dunnya;
- Phillips, Elizabeth H.;
- Cavenagh, Jamie D.;
- Adedayo, Toyin;
- Braganca, Nivette;
- Roddie, Claire;
- Streetly, Matthew;
- Schey, Steve;
- Koh, Mickey B. C.;
- Crowe, Josephine;
- Morris, Treen C.;
- Cook, Gordon;
- Smith, Paul;
- Clifton‐Hadley, Laura;
- Rabin, Neil;
- Owen, Roger;
- Yong, Kwee
Publication type:
Article
Assessment of plasma cell myeloma minimal residual disease testing by flow cytometry in an international inter‐laboratory study: Is it ready for primetime use?
Published in:
Cytometry. Part B, 2019, v. 96, n. 3, p. 201, doi. 10.1002/cyto.b.21754
By:
- Scott, Stuart D.;
- Fletcher, Matthew;
- Whitehouse, Helen;
- Whitby, Liam;
- Yuan, Constance;
- Mazzucchelli, Silvia;
- Lin, Pei;
- de Tute, Ruth;
- Dorwal, Pranav;
- Wallace, Paul K.;
- Tembhare, Prashant;
- Arroz, Maria;
- Snowden, John A.;
- Chantry, Andrew D.;
- Barnett, David
Publication type:
Article
Measuring disease levels in myeloma using flow cytometry in combination with other laboratory techniques: Lessons from the past 20 years at the Leeds Haematological Malignancy Diagnostic Service.
Published in:
Cytometry. Part B, 2016, v. 90, n. 1, p. 54, doi. 10.1002/cyto.b.21271
By:
- Rawstron, Andy C.;
- de Tute, Ruth M.;
- Haughton, J.;
- Owen, Roger G.
Publication type:
Article
Consensus guidelines on plasma cell myeloma minimal residual disease analysis and reporting.
Published in:
Cytometry. Part B, 2016, v. 90, n. 1, p. 31, doi. 10.1002/cyto.b.21228
By:
- Arroz, Maria;
- Came, Neil;
- Lin, Pei;
- Chen, Weina;
- Yuan, Constance;
- Lagoo, Anand;
- Monreal, Mariela;
- de Tute, Ruth;
- Vergilio, Jo‐Anne;
- Rawstron, Andy C.;
- Paiva, Bruno
Publication type:
Article
Immunophenotype of normal vs. myeloma plasma cells: Toward antibody panel specifications for MRD detection in multiple myeloma.
Published in:
Cytometry. Part B, 2016, v. 90, n. 1, p. 61, doi. 10.1002/cyto.b.21265
By:
- Flores‐Montero, Juan;
- de Tute, Ruth;
- Paiva, Bruno;
- Perez, José Juan;
- Böttcher, Sebastian;
- Wind, Henk;
- Sanoja, Luzalba;
- Puig, Noemí;
- Lecrevisse, Quentin;
- Vidriales, María Belén;
- van Dongen, Jacques J. M.;
- Orfao, Alberto
Publication type:
Article
Immunoglobulin M Concentration in Waldenström Macroglobulinemia: Correlation With Bone Marrow B Cells and Plasma Cells.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2013, v. 13, n. 2, p. 211, doi. 10.1016/j.clml.2013.02.018
By:
- De Tute, Ruth M.;
- Rawstron, Andy C.;
- Owen, Roger G.
Publication type:
Article
Flow cytometry and its use in the diagnosis and management of mature lymphoid malignancies.
Published in:
Histopathology, 2011, v. 58, n. 1, p. 90, doi. 10.1111/j.1365-2559.2010.03703.x
By:
- de Tute, Ruth M
Publication type:
Article
OAB-003: CARDAMON:Carfilzomib (K) maintenance following Autologous Stem Cell Transplant (ASCT) or carfilzomib-cyclophosphamide-dexamethasone (KCd) consolidation for newly diagnosed (NDTE) multiple myeloma (MM).
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S2, doi. 10.1016/S2152-2650(21)02077-2
By:
- Popat, Rakesh;
- Wilson, William;
- Camilleri, Marquita;
- Tute, Ruth De;
- Pang, Gavin;
- Jenner, Richard;
- Dadaga, Tushhar;
- Kamora, Sumaiya;
- Streetly, Matthew;
- Ramasamy, Karthik;
- Phillips, Elizabeth;
- Chapman, Mike;
- Bygrave, Ceri;
- Cavenagh, James;
- Sive, Jonathan;
- Benjamin, Reuben;
- Eccersley, Lydia;
- Hassan, Sandra;
- Willis, Fenella;
- Clifton-Hadley, Laura
Publication type:
Article
OAB-015: Minimal residual disease following autologous stem cell transplant for myeloma patients in the Myeloma XI trial: prognostic significance and the impact of lenalidomide maintenance and molecular risk.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S10, doi. 10.1016/S2152-2650(21)02089-9
By:
- De Tute, Ruth;
- Pawlyn, Charlotte;
- Cairns, David;
- Davies, Faith;
- Rawstron, Andy;
- Jones, John;
- Hockaday, Anna;
- Menzies, Tom;
- Henderson, Rowena;
- Cook, Gordon;
- Drayson, Mark;
- Jenner, Matthew;
- Kaiser, Martin;
- Gregory, Walter;
- Morgan, Gareth;
- Jackson, Graham;
- Owen, Roger
Publication type:
Article
OAB-012: Depth of response and MRD in newly diagnosed ultra high-risk myeloma and plasma cell leukemia treated with Dara-CVRd and V-MEL ASCT: results of the molecularly stratified UK OPTIMUM/MUKnine trial.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S8, doi. 10.1016/S2152-2650(21)02086-3
By:
- Kaiser, Martin;
- Hall, Andrew;
- Walker, Katrina;
- Tute, Ruth De;
- Roberts, Sadie;
- Ingleson, Emma;
- Bowles, Kristian;
- Garg, Mamta;
- Lokare, Anand;
- Messiou, Christina;
- Jackson, Graham;
- Pratt, Guy;
- Cook, Gordon;
- Drayson, Mark;
- Owen, Roger;
- Brown, Sarah;
- Jenner, Matthew
Publication type:
Article
Minimal residual disease (MRD) in Waldenström macroglobulinaemia (WM): Impact on survival outcomes with rituximab-based therapies.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e310, doi. 10.1016/j.clml.2019.09.510
By:
- De Tute, Ruth;
- Rawstron, Andrew;
- D'Sa, Shirley;
- Pratt, Guy;
- Clifton-Hadley, Laura;
- Schofield, Oliver;
- Counsell, Nicholas;
- Auer, Rebecca;
- Owen, Roger
Publication type:
Article
Outcomes of newly diagnosed multiple myeloma with deferred ASCT after achieving ≥VGPR following PAD induction in the Phase 2 PADIMAC study.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e288, doi. 10.1016/j.clml.2019.09.475
By:
- Chan, Wei Yee;
- Counsell, Nicholas;
- Popat, Rakesh;
- De Tute, Ruth;
- De-silva, Dunnya;
- Phillips, Elizabeth;
- Cavenagh, Jamie;
- Adedayo, Toyin;
- Braganca, Nivette;
- Roddie, Claire;
- Streetly, Matthew;
- Schey, Steve;
- Koh, Mickey;
- Crowe, Josephine;
- Quinn, Michael;
- Morris, Curly;
- D'Sa, Shirley;
- Virchis, Andres;
- Cook, Gordon;
- Crawley, Charles
Publication type:
Article
Sequential minimal residual disease (MRD) monitoring: Results from the UK Myeloma XI trial.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e45, doi. 10.1016/j.clml.2019.09.069
By:
- De Tute, Ruth;
- Cairns, David;
- Rawstron, Andrew;
- Pawlyn, Charlotte;
- Davies, Faith;
- Jones, John;
- Kaiser, Martin;
- Hockaday, Anna;
- Striha, Alina;
- Cook, Gordon;
- Russell, Nigel;
- Drayson, Mark;
- Jenner, Matthew;
- Gregory, Walter;
- Morgan, Gareth;
- Jackson, Graham;
- Owen, Roger
Publication type:
Article
Carfilzomib, lenalidomide, dexamethasone, and cyclophosphamide (KRdc) as induction therapy for transplant-eligible, newly diagnosed multiple myeloma patients (Myeloma XI+): Interim analysis of an open-label randomised controlled trial.
Published in:
2021
By:
- Jackson, Graham H.;
- Pawlyn, Charlotte;
- Cairns, David A.;
- de Tute, Ruth M.;
- Hockaday, Anna;
- Collett, Corinne;
- Jones, John R.;
- Kishore, Bhuvan;
- Garg, Mamta;
- Williams, Cathy D.;
- Karunanithi, Kamaraj;
- Lindsay, Jindriska;
- Rocci, Alberto;
- Snowden, John A.;
- Jenner, Matthew W.;
- Cook, Gordon;
- Russell, Nigel H.;
- Drayson, Mark T.;
- Gregory, Walter M.;
- Kaiser, Martin F.
Publication type:
journal article
Defining IgM multiple myeloma.
Published in:
American Journal of Hematology, 2011, v. 86, n. 8, p. 717, doi. 10.1002/ajh.22061
By:
- Owen, Roger G;
- Feyler, Sylvia;
- O'Connor, Sheila JM;
- Bond, Lee R;
- de Tute, Ruth M;
- Rawstron, Andy C
Publication type:
Article
Translocation t(14;16) in IgM multiple myeloma.
Published in:
British Journal of Haematology, 2011, v. 155, n. 3, p. 402, doi. 10.1111/j.1365-2141.2011.08687.x
By:
- Owen, Roger G.;
- O'Connor, Sheila J. M.;
- Bond, Lee R;
- de Tute, Ruth M;
- Rawstron, Andy C.
Publication type:
Article
B-cell chronic lymphocytic leukaemia cells show specific changes in membrane protein expression during different stages of cell cycle.
Published in:
British Journal of Haematology, 2007, v. 139, n. 4, p. 600, doi. 10.1111/j.1365-2141.2007.06790.x
By:
- Bennett, Fiona;
- Rawstron, Andy;
- Plummer, Marieth;
- De Tute, Ruth;
- Moreton, Paul;
- Jack, Andrew;
- Hillmen, Peter
Publication type:
Article

Found: 18